The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America. Here, she shares some strategies.
NextHealth PHL covers the healthcare industry in Philadelphia and the work of scientists, doctors, and healthcare companies in Cellicon Valley. NextHealth PHL puts a special emphasis on healthcare news in the vibrant cell and gene therapies sector.
Dee Messina, 77, couldn’t walk, talk, eat or write after being treated for COVID-19.
The forces driving Philly medicine are increasingly female. Meet the women at the forefront of the movement.
From fighting autoimmune diseases to destroying tumors, these are the bold ideas bubbling up from the city’s burgeoning scene.
They’re in uncharted territory, launching as many as 30 clinical trials just in the last 30 days.
The Plymouth Meeting biotech company’s vaccine has attracted the attention of world health experts and is already being tested in humans.
The results of some studies are still being recorded on paper. These local companies have developed the tools to change that.
Thomas Jefferson University population health expert David Nash wants to enlist people who’ve lost jobs to the shutdown.
Here are the local companies in the race to stop the spread of COVID-19.
From repurposed drugs to blood plasma infusions, these developments could save the world’s most at-risk COVID-19 patients.
Swarthmore professor Syon Bhanot on how to help the defiant make smarter choices.
Special allowances for cannabis businesses, like delivery and curbside pick-up, could boost the sector long after the COVID-19 pandemic is over.
The developer known for his outrageous ambition is stepping into the world of cell and gene therapy. But with this new venture, he’ll try to balance purpose and profit, for legacy’s sake.
But these portable hospital rooms invented by a Drexel alum might.
Chimeron Bio’s technology could make a future coronavirus vaccine more accessible to patients and cheaper for companies to produce.